Skip to content

Luxembourg French logo

Main menu
    • À propos
    • Notre vision, raison d’être, et mission
    • Nos valeurs
    • Nos engagements RSE
  • Nos domaines d’intervention
  • Espace Presse
  • Professionnels de Santé
  • Nous rejoindre

Nous Contacter

Back
Change Language
  • English (Luxembourg)
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Illustration of group of culturally diverse women leaders representing ESG framework

Notre vision, raison d’être, et mission

Améliorer la santé de chaque femme et faire que chaque jour soit un meilleur jour.

Quelle est notre vision ?

Améliorer la santé de chaque femme et faire que chaque jour soit un meilleur jour.

C’est notre cap, celui pour lequel nous nous efforçons de devenir une entreprise de santé mondiale se consacrant chaque jour à faire la différence pour la santé des femmes. C’est ce qui nous inspire à repousser les limites d’aujourd’hui pour offrir un avenir en meilleur santé aux femmes, mais aussi à leurs familles et à leurs proches à travers le monde.

Notre raison d’être

Nous savons que les femmes sont essentielles à un monde en meilleure santé.

Notre raison d’être est d’accompagner les femmes tout au long de leur vie et leur permettre de faire les bons choix en matière de santé.

Nous sommes animés par la recherche de solutions innovantes pour répondre à des besoins médicaux toujours non satisfaits.

Quelle est notre mission ?

Proposer des médicaments et des solutions ingénieuses* pour une vie en meilleure santé.

Nous disposons d’une solide base de plus de 60 médicaments et solutions thérapeutiques couvrant un large éventail de pathologies : contraception, fertilité, maladies cardiovasculaires, cancers, allergies, asthme et migraine.

Nous nous efforçons de rendre ces thérapies accessibles dans le monde entier, fort de notre dimension internationale, au service des patients de plus de 140 pays. La diversité de nos activités assure la croissance durable qui permettra les investissements nécessaires à la recherche et au développement de médicaments et solutions innovants répondants aux attentes de nombreuses femmes.

Nos valeurs

Notre culture est fondée sur 6 valeurs, fondement d’une culture moderne.

Découvrir nos valeurs

* Intelligentes, originales, inventives

BE-NON-110118 – February 2025

Luxembourg French logo
  • Politique de gestion de cookies
  • Politique de confidentialité
  • Conditions générales d’utilisation
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept